Excedr

Lyophilizers are essential for stability studies and biotech workflows, but costs vary widely. This guide breaks down price ranges, hidden expenses, and whether buying, leasing, or outsourcing makes sense for your stage and budget.

An ICP-MS can transform a biotech lab, but costs run far beyond the sticker price. This guide breaks down price ranges, hidden expenses, and practical options for startups deciding whether to buy, lease, or outsource.

GC-MS systems are essential in biotech, but costs extend far beyond the sticker price. This guide breaks down price ranges, hidden expenses, and decision frameworks—helping founders and operators choose the right path for their stage and workflo

Ansa Biotechnologies secures $54M+ Series B to advance enzymatic DNA synthesis—Excedr covers this major biotech funding round.

Cartography Biosciences secures $67M Series B to advance precision cancer immunotherapies—Excedr covers this major biotech funding round.

Leasing lab equipment helps biotech labs stay flexible—cutting upfront costs, reducing downtime, and keeping research aligned with shifting milestones.

See how equipment leasing helps biotech startups hit milestones faster by preserving cash flow, cutting upfront costs, and accelerating R&D timelines.

Excedr covers Predicta Biosciences’ $23.4M raise to advance liquid biopsy diagnostics for multiple myeloma, replacing painful bone marrow biopsies with blood-based testing.

Axon Therapies pioneers a breakthrough in heart failure treatment with splanchnic nerve ablation—Excedr covers this major biotech funding round.

Star Therapeutics advances antibody therapies for rare blood disorders—Excedr covers this major biotech funding round.